179 related articles for article (PubMed ID: 21938452)
1. Safety of immunomodulatory therapy in patients with bronchiectasis associated with rheumatic disease and IBD: a retrospective and cohort analysis.
Goeminne PC; Verschueren P; Scheers H; Dupont LJ
Clin Rheumatol; 2012 Feb; 31(2):367-73. PubMed ID: 21938452
[TBL] [Abstract][Full Text] [Related]
2. Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases.
Geri G; Dadoun S; Bui T; Del Castillo Pinol N; Paternotte S; Dougados M; Gossec L
BMC Infect Dis; 2011 Nov; 11():304. PubMed ID: 22046967
[TBL] [Abstract][Full Text] [Related]
3. Effect of macrolide on lung function and computed tomography (CT) score in non-cystic fibrosis bronchiectasis.
Goeminne PC; Soens J; Scheers H; De Wever W; Dupont L
Acta Clin Belg; 2012; 67(5):338-46. PubMed ID: 23189541
[TBL] [Abstract][Full Text] [Related]
4. Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.
Zhuo GY; He Q; Xiang-Lian L; Ya-Nan Y; Si-Te F
Pulm Pharmacol Ther; 2014 Oct; 29(1):80-8. PubMed ID: 24594263
[TBL] [Abstract][Full Text] [Related]
5. Incidence of patients with non-cystic fibrosis bronchiectasis in Germany - A healthcare insurance claims data analysis.
Diel R; Ewig S; Blaas S; Jacob C; Juelich F; Korfmann G; Sohrab S; Sutharsan S; Rademacher J
Respir Med; 2019 May; 151():121-127. PubMed ID: 31047108
[TBL] [Abstract][Full Text] [Related]
6. Persistently normal blood tests in patients taking methotrexate for RA or azathioprine for IBD: a retrospective cohort study.
Fraser SD; Lin SX; Stammers M; Culliford D; Ibrahim K; Barrett R; Howard C; Johnson R; Barnes N; Batchelor J; Holroyd C; Adams J; Rischin A; Roderick P; Rutter P; Edwards CJ
Br J Gen Pract; 2022 Jul; 72(720):e528-e537. PubMed ID: 35256384
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease and the lung: is there a link between surgery and bronchiectasis?
Kelly MG; Frizelle FA; Thornley PT; Beckert L; Epton M; Lynch AC
Int J Colorectal Dis; 2006 Dec; 21(8):754-7. PubMed ID: 16625374
[TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers.
Stass H; Nagelschmitz J; Kappeler D; Sommerer K; Kietzig C; Weimann B
J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):53-63. PubMed ID: 27448179
[TBL] [Abstract][Full Text] [Related]
9. Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials.
Paredes Aller S; Quittner AL; Salathe MA; Schmid A
Expert Rev Respir Med; 2018 Sep; 12(9):769-782. PubMed ID: 30025482
[TBL] [Abstract][Full Text] [Related]
10. Suspecting non-cystic fibrosis bronchiectasis: What the busy primary care clinician needs to know.
Maselli DJ; Amalakuhan B; Keyt H; Diaz AA
Int J Clin Pract; 2017 Feb; 71(2):. PubMed ID: 28238229
[TBL] [Abstract][Full Text] [Related]
11. Primary Immunodeficiency Disorders in children with Non-Cystic Fibrosis Bronchiectasis.
Çağdaş D; Pehlivantürk Kizılkan M; Tagiyev A; Emiralioğlu N; Keleş A; Yalçın E; Doğru D; Özçelik U; Kiper N; Tezcan İ
Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):271-276. PubMed ID: 32372587
[No Abstract] [Full Text] [Related]
12. The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases.
El Miedany Y; Youssef S; Ahmed I; El Gaafary M
Am J Gastroenterol; 2006 Feb; 101(2):311-7. PubMed ID: 16454836
[TBL] [Abstract][Full Text] [Related]
13. Experience with etanercept in an academic medical center: are infection rates increased?
Phillips K; Husni ME; Karlson EW; Coblyn JS
Arthritis Rheum; 2002 Feb; 47(1):17-21. PubMed ID: 11932873
[TBL] [Abstract][Full Text] [Related]
14. Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide series.
Toussirot É; Houvenagel É; Goëb V; Fouache D; Martin A; Le Dantec P; Dernis E; Wendling D; Ansemant T; Berthelot JM; Bader-Meunier B; Kantelip B;
Joint Bone Spine; 2012 Oct; 79(5):457-63. PubMed ID: 22088934
[TBL] [Abstract][Full Text] [Related]
15. [The pulmonological manifestations of rheumatoid arthritis].
Bernscherer G; Karabélyos C; Tarján Z
Orv Hetil; 2008 Jul; 149(29):1355-61. PubMed ID: 18617467
[TBL] [Abstract][Full Text] [Related]
16. Management of Non-Cystic Fibrosis Bronchiectasis.
Dull SK; Havlat BD; Sanley MJ; Malesker MA
Consult Pharm; 2018 Nov; 33(11):658-666. PubMed ID: 30458908
[No Abstract] [Full Text] [Related]
17. Outpatient Parenteral Antimicrobial Treatment for Non-Cystic Fibrosis Bronchiectasis Exacerbations: A Prospective Multicentre Observational Cohort Study.
López-Cortés LE; Ayerbe-García R; Carrasco-Hernández L; Fraile-Ramos E; Carmona-Caballero JM; Quintana-Gallego E; Valido-Morales A; Praena J; Pachón-Diaz J;
Respiration; 2019; 98(4):294-300. PubMed ID: 31288243
[TBL] [Abstract][Full Text] [Related]
18. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective.
Joish VN; Spilsbury-Cantalupo M; Operschall E; Luong B; Boklage S
Appl Health Econ Health Policy; 2013 Jun; 11(3):299-304. PubMed ID: 23580074
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasis.
Amaro R; Panagiotaraka M; Alcaraz V; Torres A
Expert Rev Respir Med; 2018 Aug; 12(8):683-691. PubMed ID: 30010445
[TBL] [Abstract][Full Text] [Related]
20. Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-alpha antagonist therapy.
Peña-Sagredo JL; Fariñas MC; Perez-Zafrilla B; Cruz-Valenciano A; Crespo M; Joven-Ibañez B; Riera E; Manero-Ruiz FJ; Chalmeta I; Hernández MV; Rodríguez-Gómez M; Maíz O; López R; Cobo T; Pita J; Carmona L; Gonzalez-Gay MA;
Clin Exp Rheumatol; 2009; 27(6):920-5. PubMed ID: 20149306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
